Christopher Ramsden, M.D., Ph.D.

The objectives of the Lipid Peroxidation Unit are: (1) to delineate the roles of lipid peroxidation and lipid-related degeneration in age-related diseases, with an emphasis on chronic pain and Alzheimer’s disease, and (2) to translate discoveries into targeted, safe and effective diet and drug-based treatments. The Unit applies an interdisciplinary, translational approach—comprising randomized controlled trials, postmortem studies using traditional and multiplex immunohistochemistry, synthetic and analytical chemistry, and cellular models—to achieve these objectives.

Dr. Ramsden is a Clinical Investigator in the Intramural Program of the NIH and CAPT in the Commissioned Corps of the U.S. Public Health Service. Following completion of a medical internship and residency, Dr. Ramsden was a clinical research fellow at UNC-Chapel Hill before joining the Intramural Program of the NIAAA in 2009. In 2016, he was appointed to a Clinical Tenure-Track position as the Head of the Lipid Peroxidation Unit, within the Laboratory of Clinical Investigation in the NIA in Baltimore, MD, with a joint Tenure-Track appointment in the Intramural Program of NIAAA in Bethesda, MD. Dr. Ramsden currently leads an interdisciplinary, translational research program investigating the roles of lipid mediators and lipid-related mechanisms underlying the pathogenesis of chronic pain and Alzheimer’s disease.